EVIDENCE SPOTLIGHT: Vibroacoustic Music for Pain, Anxiety, and Symptom Relief During Cancer Care

STUDY OVERVIEW

Cancer treatment can involve pain, anxiety, fatigue, nausea, tension, and other symptoms that make infusion visits physically and emotionally difficult.

This six-week clinical program evaluation examined whether vibroacoustic music could help reduce pain, anxiety, tension, and other symptoms in patients receiving care at the Ella Milbanks Foshay Cancer Center in Jupiter, Florida.

More than 40 patients participated. During 30-minute sessions, patients reclined in a Somatron vibroacoustic chair while listening to music and feeling sound-generated vibration throughout the body.

The program reported reductions of more than 60% in pain, symptoms, and anxiety following treatment sessions. Patients also described physical and emotional relief, while nurses reported that the program was easy to facilitate and improved the treatment experience.

Because this was a nursing-practice program evaluation rather than a controlled clinical trial, the findings should be interpreted as supportive real-world evidence rather than definitive proof of effectiveness.

Vibroacoustic music refers to music that is both heard through the ears and physically felt through sound-generated vibration. It is one form of vibroacoustic therapy, with the musical experience serving as both the audible and vibratory component of the intervention. In this program, the Somatron recliner transmitted the music’s low-frequency vibrations through the patient’s body while the music was heard normally.

STUDY DETAILS

Study Type: Six-week clinical program evaluation described in a nursing-practice article

Participants: More than 40 cancer patients

Setting: Ella Milbanks Foshay Cancer Center at Jupiter Medical Center in Jupiter, Florida

Treatment Context: Cancer infusion care

Session Length: 30 minutes

Intervention: Vibroacoustic music delivered through a Somatron Clinical Motorized Recliner

Participant Position: Reclined in a position described by the article as Trendelenburg, with the legs elevated and the hips and knees at approximately 90-degree angles

Primary Focus: Pain, anxiety, tension, and treatment-related symptoms

Comparison Group: None

Program Duration: Six weeks

Data Collection: Before-and-after symptom ratings for each session

Published As: Nursing-practice article rather than a formal peer-reviewed clinical trial report

WHAT THEY DID

The Foshay Cancer Center developed the program after reviewing a vibroacoustic pain-management program used at the National Institutes of Health.

Patients receiving infusion treatment were offered the opportunity to recline in a Somatron vibroacoustic chair, close their eyes, and receive music that was both heard and physically felt through the chair.

Each session lasted approximately 30 minutes.

The intervention combined several elements:

  • Music selected for its calming or anxiety-reducing qualities

  • Sound-generated vibration delivered throughout the body

  • A supportive reclining position intended to reduce muscular and spinal tension

  • A quieter, more private treatment environment

Nurses recorded patients’ pain, symptoms, anxiety, and tension before and after each session.

The NIH provided assistance with the evaluation design and computation of the results.

OUTCOMES MEASURED

The evaluation measured:

  • Pain intensity using a Visual Analog Scale

  • Tension using the Poppin Seven-Point Self Report

  • The nature and intensity of patient-reported symptoms before and after each session

  • Symptoms described in the article included anxiety, fatigue, nausea, headache, anger, and other concerns

  • Patient comments about the treatment experience

  • Nurse observations about feasibility and patient response

The article does not provide exact baseline scores, separate numerical results for each symptom, or a complete statistical analysis.

MAJOR FINDINGS

The six-week evaluation reported a reduction of more than 60% in pain, symptoms, and anxiety after vibroacoustic music sessions.

The article describes reductions across symptoms that included:

  • Pain

  • Anxiety

  • Fatigue

  • Nausea

  • Headache

  • Tension

  • Anger

  • Other reported symptoms

The findings were based on comparisons between patients’ pre-session and post-session ratings.

The article does not provide separate percentages for each symptom, detailed statistical values, or a complete table of results. The reported reduction should therefore be understood as an overall program-evaluation finding rather than a fully documented clinical-trial outcome.

ADDITIONAL REPORTED BENEFITS

Patients frequently reported that they:

  • Felt physically more comfortable

  • Experienced mental and emotional relief

  • Left treatment feeling better than when they arrived

  • Appreciated the comfort of the recliner

  • Enjoyed the combination of music and vibration

Nurses reported that:

  • The equipment was easy to use

  • The program required little additional time

  • Patients responded positively

  • The intervention increased nurses’ satisfaction with the care experience

  • The music sometimes had a calming effect on staff as well

The program was later expanded, with Somatron recliners installed at six infusion stations in the remodeled cancer center.

The article also reports that the program helped the center address pain-management requirements and appeared useful in other clinical settings.

CLINICAL IMPLICATIONS

This program evaluation suggests that vibroacoustic music may be a practical complementary option for easing discomfort during cancer infusion treatment.

The intervention may be especially relevant in settings where patients remain seated or reclined for extended periods and may experience pain, nausea, tension, anxiety, fatigue, or treatment-related distress.

The program is notable because it was delivered by nurses in a busy clinical environment. The staff reported that it was easy to implement and required little additional time, suggesting that vibroacoustic interventions may be feasible in supportive-care settings.

However, several limitations affect how strongly the findings can be interpreted:

  • There was no control or comparison group.

  • Participants were not randomly assigned.

  • The article does not report the exact number of completed sessions.

  • The cancer diagnoses and treatment regimens were not described.

  • The article does not provide detailed statistical analyses.

  • Individual symptom results were not reported separately.

  • The effect of vibration cannot be separated from the effects of music, reclining, privacy, attention, and rest.

  • The report was published as a nursing-practice article rather than a formal clinical study.

  • Long-term effects were not measured.

  • Adverse-event monitoring was not described.

The findings support further study of vibroacoustic music as a supportive-care intervention, not as a treatment for cancer itself or as a replacement for medical symptom management.

RELEVANCE TO SICKLE CELL SUPPORT

This program did not involve people with sickle cell disease. It was selected because several symptoms addressed during cancer infusion care—pain, anxiety, fatigue, nausea, headache, muscular tension, and emotional distress—may also affect people living with sickle cell disease during treatment, recovery, or periods of increased symptom burden.

The evaluation reported reductions of more than 60% in pain, anxiety, and other symptoms following 30-minute vibroacoustic music sessions. Patients also described greater physical comfort and mental and emotional relief.

The program is especially relevant because vibroacoustic music was integrated into an existing medical-care environment and delivered while patients were already seated for infusion treatment. This suggests a possible model for studying VAT as a comfort-focused supportive service during medical appointments or recovery periods.

However, these findings do not show that vibroacoustic therapy treats sickle cell disease, prevents vaso-occlusive crises, or reduces sickle cell pain specifically. The evaluation involved cancer patients, had no control group, and did not report separate results for each symptom.

Research conducted directly with people living with sickle cell disease is still needed.

WHY IT MATTERS

Supportive care is not separate from the treatment experience. Pain, anxiety, fatigue, nausea, and tension can shape how patients tolerate medical care and how they feel during and after treatment.

This program evaluation is important because it shows how vibroacoustic music was incorporated into a real-world cancer center rather than tested only in a laboratory.

The intervention was:

  • Noninvasive

  • Delivered during existing treatment

  • Facilitated by nursing staff

  • Well received by patients

  • Reported as practical to implement

The results also show why real-world clinical observations can be valuable even when they do not meet the standards of a controlled trial. They can identify promising uses, demonstrate feasibility, and guide more rigorous research.

At the same time, the limited reporting means the results should not be overstated. The evaluation supports the potential role of vibroacoustic music in comfort and symptom management, but it does not establish cause and effect.

PUBLICATION & RESEARCH ACCESS

Article: Nurses Ease Pain in Cancer Center with Music

Authors: Valerie Coope, RN, OCN, and Chris Brewer, MA, FAMI

Publication: Nursing Spectrum

Publication Date: February 10, 2003

Setting: Ella Milbanks Foshay Cancer Center, Jupiter Medical Center, Florida

Program Type: Six-week nursing-led vibroacoustic music program evaluation

Evidence Classification: Clinical program evaluation reported in a nursing-practice article

Related Background Research: The article references the NIH vibroacoustic program and George Patrick’s 1999 publication, The Effects of Vibroacoustic Music on Symptom Reduction: Inducing the Relaxation Response through Good Vibrations.

Research Access Note: The available document is a two-page practice article summarizing the program. It does not include a full research protocol, detailed statistical tables, or complete participant-level data.

Previous
Previous

EVIDENCE SPOTLIGHT: Music Therapy for Quality of Life and Chronic Pain in Adults with Sickle Cell Disease

Next
Next

EVIDENCE SPOTLIGHT: Vibroacoustic Stimulation and Stress Regulation